Amersham Sues PerkinElmer Over Drug Technology Patents

Law360, New York (October 24, 2003, 12:00 AM EDT) -- Amersham Biosciences and its parent, U.K.-based Amersham PLC, have filed a lawsuit in the U.S. District Court in Newark, NJ, against PerkinElmer Inc., alleging that PerkinElmer infringed on two of Amersham's patents for technology used in the development of new drugs.

The complaint alleges that PerkinElmer's ViewLux and Image FlashPlate products infringe on Amersham patents for technologies that use luminescence and fluorescence to analyze compounds being screened for use in the development of new drugs. Amersham said PerkinElmer continues to sell those products despite being advised...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.